GENE ONLINE|News &
Opinion
Blog

2025-06-18| APACUS BIO 2025

Investor Trust and Market Timing Shape the New IPO Playbook

by Denisse Sandoval
Share To
From left to right: Kimberly Ha, HHA Advisors; Andrew Lam, Ally Bridge Group; Jakob Dupont, Sofinnova Investments; Chirag Surti, Morgan Stanley; Jennifer Fang, Wilson Sonsini; & Jordan Saxe, NASDAQ. Image source: GeneOnline
At the 2025 BIO International Convention, the panel “Preparing for an IPO: Best Practices for Success” brought together leaders from across the biotech investment and advisory landscape to share practical guidance for companies eyeing the public markets. Speakers included Jakob Dupont, Executive Partner at Sofinnova Investments; Jennifer Fang, Partner at Wilson Sonsini; Andrew Lam, Managing … Investor Trust and Market Timing Shape the New IPO Playbook Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.

GO Prime with only $1.49 now

LATEST
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Actavis Pharma Updates Ciclopirox Shampoo Prescribing Information as of September 10, 2026
2026-09-10
Scroll to Top